Vanguard Group’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.44M | Sell |
269,002
-1,304
| -0.5% | -$11.8K | ﹤0.01% | 3471 |
|
|
2025
Q1 | $2.58M | Sell |
270,306
-4,685
| -2% | -$44.7K | ﹤0.01% | 3401 |
|
|
2024
Q4 | $3.09M | Buy |
274,991
+1,466
| +0.5% | +$16.5K | ﹤0.01% | 3437 |
|
|
2024
Q3 | $3.93M | Buy |
273,525
+5,357
| +2% | +$77K | ﹤0.01% | 3357 |
|
|
2024
Q2 | $4.63M | Buy |
268,168
+45,066
| +20% | +$778K | ﹤0.01% | 3294 |
|
|
2024
Q1 | $4.45M | Buy |
223,102
+1,420
| +0.6% | +$28.3K | ﹤0.01% | 3344 |
|
|
2023
Q4 | $2.33M | Buy |
221,682
+1,729
| +0.8% | +$18.2K | ﹤0.01% | 3551 |
|
|
2023
Q3 | $1.94M | Sell |
219,953
-62,262
| -22% | -$550K | ﹤0.01% | 3595 |
|
|
2023
Q2 | $2.72M | Sell |
282,215
-70,109
| -20% | -$676K | ﹤0.01% | 3564 |
|
|
2023
Q1 | $4.86M | Buy |
352,324
+7,800
| +2% | +$108K | ﹤0.01% | 3316 |
|
|
2022
Q4 | $5.24M | Buy |
344,524
+88
| +0% | +$1.34K | ﹤0.01% | 3281 |
|
|
2022
Q3 | $3.13M | Sell |
344,436
-9,800
| -3% | -$89.2K | ﹤0.01% | 3565 |
|
|
2022
Q2 | $3M | Sell |
354,236
-20,964
| -6% | -$178K | ﹤0.01% | 3626 |
|
|
2022
Q1 | $7.36M | Buy |
375,200
+225,213
| +150% | +$4.42M | ﹤0.01% | 3311 |
|
|
2021
Q4 | $3.65M | Buy |
149,987
+693
| +0.5% | +$16.9K | ﹤0.01% | 3784 |
|
|
2021
Q3 | $5.83M | Buy |
149,294
+27,876
| +23% | +$1.09M | ﹤0.01% | 3558 |
|
|
2021
Q2 | $5.46M | Buy |
121,418
+15,157
| +14% | +$681K | ﹤0.01% | 3547 |
|
|
2021
Q1 | $3.62M | Buy |
106,261
+94,952
| +840% | +$3.24M | ﹤0.01% | 3683 |
|
|
2020
Q4 | $412K | Buy |
+11,309
| New | +$412K | ﹤0.01% | 3994 |
|